MediGene (MDG1) Given a €16.50 Price Target at Independent Research

Share on StockTwits

Independent Research set a €16.50 ($19.64) price objective on MediGene (ETR:MDG1) in a research note issued to investors on Friday morning. The firm currently has a neutral rating on the stock.

Several other equities analysts have also recently issued reports on the company. Baader Bank set a €22.00 ($26.19) price target on MediGene and gave the company a buy rating in a research report on Monday, April 16th. Oddo Bhf set a €13.00 ($15.48) price target on MediGene and gave the company a neutral rating in a research report on Friday, March 23rd.

MDG1 opened at €14.29 ($17.01) on Friday. MediGene has a one year low of €8.53 ($10.15) and a one year high of €19.27 ($22.94).

MediGene Company Profile

Medigene AG, a biotechnology company, develops immunotherapy platforms to treat a range of cancers in various stages. It operates through two segments, Immunotherapies and Other Products. The company develops Dendritic cell vaccines in phase I/II clinical trials; and T-cell receptor-modified T cells and T-cell-specific monoclonal antibodies in preclinical development phase.

Receive News & Ratings for MediGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediGene and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

iShares Core S&P Mid-Cap ETF  Shares Sold by Ballentine Partners LLC
iShares Core S&P Mid-Cap ETF Shares Sold by Ballentine Partners LLC
Baillie Gifford & Co. Acquires 3,162 Shares of British American Tobacco PLC
Baillie Gifford & Co. Acquires 3,162 Shares of British American Tobacco PLC
Ambarella Inc  Stake Boosted by Baillie Gifford & Co.
Ambarella Inc Stake Boosted by Baillie Gifford & Co.
Veeco Instruments Inc.  Position Boosted by Baillie Gifford & Co.
Veeco Instruments Inc. Position Boosted by Baillie Gifford & Co.
Bahl & Gaynor Inc. Acquires 543 Shares of Visa
Bahl & Gaynor Inc. Acquires 543 Shares of Visa
Somewhat Favorable Media Coverage Somewhat Unlikely to Impact U.S. Energy  Stock Price
Somewhat Favorable Media Coverage Somewhat Unlikely to Impact U.S. Energy Stock Price


© 2006-2018 Ticker Report. Google+.